Mode
Text Size
Log in / Sign up
Phase 4 Completed N=15 Randomized Single-blind Basic Science

Effects of Garlic Supplements on Opioids in Healthy Volunteers

Healthy, No Evidence of Disease
Source: ClinicalTrials.gov NCT00499460 ↗
Enrolled (actual)
15
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Oxycodone Oral Clearance — 1.82; 2.04 L/min — p=>0.05
◆ Published Evidence
No publication linked

No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.

Summary

RATIONALE: Garlic supplements may alter the pharmacokinetics of oxycodone, thereby affecting its effectiveness as an opioid analgesic for the relief of moderate or severe pain. PURPOSE: This randomized phase 4 trial is studying how garlic supplements may change the pharmacokinetics of oxycodone and its analgesic and side effects in healthy volunteers.

Outcome Measures

OutcomeResultp-value
PRIMARY
Oxycodone Oral Clearance
1.82; 2.04 >0.05
SECONDARY
Cold Pressor Tolerance AUC
3.513; 3.715 >0.05
SECONDARY
Somatic Side Effects Total Score
0.560; 0.711 >0.05
SECONDARY
Cognitive-Affective Side Effects Total Score
1.884; 1.714 >0.05
SECONDARY
Oral Midazolam Test
2491; 2495 >0.05
SECONDARY
Oral Digoxin Test
231; 226 >0.05

Eligibility Criteria

INCLUSION CRITERIA

  • Healthy volunteer
  • Body mass index 20-32

EXCLUSION CRITERIA

  • Not pregnant
  • No history of cardiopulmonary, liver, renal, endocrine, neurologic, or psychiatric disease
  • No anemia
  • No known adverse reactions to opioids, benzodiazepines, cardiac glycosides, or garlic supplements
  • No known allergy or hypersensitivity to sulfur-containing food or drugs
  • No significant gastrointestinal intolerance to lactose in dairy products
  • No recent history of alcohol or substance abuse
  • No history of or concurrent heavy daily consumption of allium vegetables (i.e., garlic, shallots, leeks, and chives)
  • No handicaps due to visual and hearing impairments
  • No resting heart rate < 50 beats per minutes
  • No abnormal cardiac rhythm by EKG
  • No unusually sensitive response or resistance to pain stimulation (Cold Pressor Test)
  • Must be right handed
  • No color blindness
  • No history of learning disabilities or dyslexia
  • Must be literate and proficient in English
  • Must be a nonsmoker
  • No concurrent medication except oral contraceptives
  • No concurrent grapefruit or grapefruit juice
  • No other concurrent over-the-counter herbal products or herbal tea
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00499460). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search